Zurich, Switzerland

Weldy Bonilla Pinschewer

This inventor holds 1 USPTO granted patent. Top assignee: Prionics Ag. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weldy Bonilla Pinschewer. Retrieved from https://idiyas.com/inventor/weldy-bonilla-pinschewer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weldy Bonilla Pinschewer: Innovator in Diagnostic Compositions

Introduction

Weldy Bonilla Pinschewer is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of diagnostics, particularly in the detection of antibodies in infected samples. His work is essential for advancing medical diagnostics and improving health outcomes.

Latest Patents

Weldy Bonilla Pinschewer holds 1 patent for a diagnostic composition designed to detect antibodies in samples obtained from animals or humans infected by specific pathogens. This innovative patent includes at least one peptide containing a series of amino acids that form a continuous or discontinuous epitope recognized by sera from pigs infected with Prionics AG.

Career Highlights

Throughout his career, Weldy has demonstrated a commitment to research and innovation in the field of diagnostics. His work at Prionics AG has positioned him as a key player in developing solutions that enhance the detection of infectious diseases.

Collaborations

Weldy has collaborated with talented individuals such as Patrik Buholzer and Alex Raber, contributing to a dynamic research environment that fosters innovation and progress in diagnostic technologies.

Conclusion

Weldy Bonilla Pinschewer's contributions to the field of diagnostics through his innovative patent and collaborative efforts highlight his importance as an inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…